Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1994 Mar;111(3):673–680. doi: 10.1111/j.1476-5381.1994.tb14790.x

Vasorelaxant effect of mexiletine in mesenteric resistance arteries of rats.

Y Dohi 1, M Kojima 1, K Sato 1
PMCID: PMC1910102  PMID: 8019745

Abstract

1. The vascular action of mexiletine, a class Ib antiarrhythmic agent, was investigated in the mesenteric resistance arteries of rats. 2. The second order branch of the mesenteric artery was cut into rings and changes in isometric tension were recorded. 3. Mexiletine (10(-6) -10(-3) M) evoked concentration-dependent, endothelium-independent relaxations in arteries contracted with noradrenaline. 4. Mexiletine (10(-4) M) did not affect the contraction induced by noradrenaline in Ca(2+)-free solution, while the compound inhibited the contraction induced by CaCl2 in noradrenaline-activated arteries. 5. The relaxation induced by mexiletine was less pronounced in arteries contracted with high KCl than in those contracted with noradrenaline. 6. Mexiletine induced identical relaxations in arteries contracted with noradrenaline in high KCl solution containing verapamil and in Krebs solution. 7. Thus, mexiletine induces relaxations by inhibiting transmembrane Ca2+ movement, but not Ca2+ release from the intracellular store site in mesenteric resistance arteries of rats. It is speculated that mexiletine possesses greater inhibitory effects against noradrenaline-activated, verapamil-insensitive (receptor-operated) Ca2+ channels than against verapamil-sensitive (voltage-dependent) channels.

Full text

PDF
673

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ARUNLAKSHANA O., SCHILD H. O. Some quantitative uses of drug antagonists. Br J Pharmacol Chemother. 1959 Mar;14(1):48–58. doi: 10.1111/j.1476-5381.1959.tb00928.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Altura B. M., Altura B. T. Effects of local anesthetics, antihistamines, and glucocorticoids on peripheral blood flow and vascular smooth muscle. Anesthesiology. 1974 Aug;41(2):197–214. doi: 10.1097/00000542-197408000-00009. [DOI] [PubMed] [Google Scholar]
  3. Beltrame J., Aylward P. E., McRitchie R. J., Chalmers J. P. Comparative haemodynamic effects of lidocaine, mexiletine, and disopyramide. J Cardiovasc Pharmacol. 1984 May-Jun;6(3):483–490. [PubMed] [Google Scholar]
  4. Brayden J. E., Nelson M. T. Regulation of arterial tone by activation of calcium-dependent potassium channels. Science. 1992 Apr 24;256(5056):532–535. doi: 10.1126/science.1373909. [DOI] [PubMed] [Google Scholar]
  5. Chiavarelli M., Chiavarelli R., Fabi F., Stati T., del Basso P. Vascular effects of lignocaine after coronary artery surgery. Lancet. 1990 May 5;335(8697):1101–1102. doi: 10.1016/0140-6736(90)92678-b. [DOI] [PubMed] [Google Scholar]
  6. Diederich D., Yang Z. H., Bühler F. R., Lüscher T. F. Impaired endothelium-dependent relaxations in hypertensive resistance arteries involve cyclooxygenase pathway. Am J Physiol. 1990 Feb;258(2 Pt 2):H445–H451. doi: 10.1152/ajpheart.1990.258.2.H445. [DOI] [PubMed] [Google Scholar]
  7. Dohi Y., Aoki K., Fujimoto S., Kojima M., Matsuda T. Alteration in sarcoplasmic reticulum-dependent contraction of tail arteries in response to caffeine and noradrenaline in spontaneously hypertensive rats. J Hypertens. 1990 Mar;8(3):261–267. [PubMed] [Google Scholar]
  8. Dohi Y., Thiel M. A., Bühler F. R., Lüscher T. F. Activation of endothelial L-arginine pathway in resistance arteries. Effect of age and hypertension. Hypertension. 1990 Aug;16(2):170–179. doi: 10.1161/01.hyp.16.2.170. [DOI] [PubMed] [Google Scholar]
  9. Endo M. Calcium release from the sarcoplasmic reticulum. Physiol Rev. 1977 Jan;57(1):71–108. doi: 10.1152/physrev.1977.57.1.71. [DOI] [PubMed] [Google Scholar]
  10. Ishida Y., Shibata S. Characteristics contractile response to the calcium ionophore, A23187, in guinea-pig vas deferens. Br J Pharmacol. 1980;71(2):581–583. doi: 10.1111/j.1476-5381.1980.tb10976.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Itoh T., Kuriyama H., Suzuki H. Differences and similarities in the noradrenaline- and caffeine-induced mechanical responses in the rabbit mesenteric artery. J Physiol. 1983 Apr;337:609–629. doi: 10.1113/jphysiol.1983.sp014645. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Johns R. A., DiFazio C. A., Longnecker D. E. Lidocaine constricts or dilates rat arterioles in a dose-dependent manner. Anesthesiology. 1985 Feb;62(2):141–144. doi: 10.1097/00000542-198502000-00008. [DOI] [PubMed] [Google Scholar]
  13. Josephson I., Sperelakis N. Local anesthetic blockade of Ca2+ -mediated action potentials in cardiac muscle. Eur J Pharmacol. 1976 Dec;40(2):201–208. doi: 10.1016/0014-2999(76)90053-4. [DOI] [PubMed] [Google Scholar]
  14. Kitagawa H., Takeda F., Kohei H. Inhibition of sympathetic nervous system by mexiletine, an antiarrhythmic agent, and its antagonism against ouabain. Arzneimittelforschung. 1985;35(1A):356–359. [PubMed] [Google Scholar]
  15. Kunze H., Nahas N., Traynor J. R., Wurl M. Effects of local anaesthetics on phospholipases. Biochim Biophys Acta. 1976 Jul 20;441(1):93–102. doi: 10.1016/0005-2760(76)90284-8. [DOI] [PubMed] [Google Scholar]
  16. Monk J. P., Brogden R. N. Mexiletine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in the treatment of arrhythmias. Drugs. 1990 Sep;40(3):374–411. doi: 10.2165/00003495-199040030-00005. [DOI] [PubMed] [Google Scholar]
  17. Monuszko E., Halevy S., Freese K., Liu-Barnett M., Altura B. Vasoactive actions of local anaesthetics on human isolated umbilical veins and arteries. Br J Pharmacol. 1989 Jun;97(2):319–328. doi: 10.1111/j.1476-5381.1989.tb11957.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Nagao T., Vanhoutte P. M. Hyperpolarization contributes to endothelium-dependent relaxations to acetylcholine in femoral veins of rats. Am J Physiol. 1991 Oct;261(4 Pt 2):H1034–H1037. doi: 10.1152/ajpheart.1991.261.4.H1034. [DOI] [PubMed] [Google Scholar]
  19. Nagasako S., Hayashibara M., Katagiri Y., Iwamoto K. Salivary excretion of mexiletine after bolus intravenous administration in rats. J Pharm Pharmacol. 1992 Jan;44(1):55–57. doi: 10.1111/j.2042-7158.1992.tb14364.x. [DOI] [PubMed] [Google Scholar]
  20. Nosaka S., Kamaya H., Ueda I., Wong K. C. Smooth muscle contraction and local anesthetics: calmodulin-dependent myosin light-chain kinase. Anesth Analg. 1989 Oct;69(4):504–510. [PubMed] [Google Scholar]
  21. Ono K., Kiyosue T., Arita M. Comparison of the inhibitory effects of mexiletine and lidocaine on the calcium current of single ventricular cells. Life Sci. 1986 Oct 20;39(16):1465–1470. doi: 10.1016/0024-3205(86)90552-7. [DOI] [PubMed] [Google Scholar]
  22. Perlmutter N. S., Wilson R. A., Edgar S. W., Sanders W., Greenberg B. H., Tanz R. Vasodilatory effects of lidocaine on epicardial porcine coronary arteries. Pharmacology. 1990;41(5):280–285. doi: 10.1159/000138734. [DOI] [PubMed] [Google Scholar]
  23. Rossi F., Ruggiero E., Scafuro M. A., Giasi M., Mazzeo V., Bile G., Lamparelli E., Marmo E. Possible adverse effects on the cardiovascular system of an antiarrhythmic drug mexiletine. Arch Toxicol Suppl. 1984;7:510–514. doi: 10.1007/978-3-642-69132-4_109. [DOI] [PubMed] [Google Scholar]
  24. Shirayama T., Inoue D., Inoue M., Tatsumi T., Yamahara Y., Asayama J., Katsume H., Nakagawa M. Electrophysiological effects of sodium channel blockers on guinea pig left atrium. J Pharmacol Exp Ther. 1991 Nov;259(2):884–893. [PubMed] [Google Scholar]
  25. Sturgess N. C., Ashford M. L., Cook D. L., Hales C. N. The sulphonylurea receptor may be an ATP-sensitive potassium channel. Lancet. 1985 Aug 31;2(8453):474–475. doi: 10.1016/s0140-6736(85)90403-9. [DOI] [PubMed] [Google Scholar]
  26. Swamy V. C., Ticku M., Triggle C. R., Triggle D. J. The action of the ionophores, X-537A and A-23187, on smooth muscle. Can J Physiol Pharmacol. 1975 Dec;53(6):1108–1114. doi: 10.1139/y75-154. [DOI] [PubMed] [Google Scholar]
  27. Vane J. R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol. 1971 Jun 23;231(25):232–235. doi: 10.1038/newbio231232a0. [DOI] [PubMed] [Google Scholar]
  28. Vaughan Williams E. M. A classification of antiarrhythmic actions reassessed after a decade of new drugs. J Clin Pharmacol. 1984 Apr;24(4):129–147. doi: 10.1002/j.1552-4604.1984.tb01822.x. [DOI] [PubMed] [Google Scholar]
  29. Vozeh S., Katz G., Steiner V., Follath F. Population pharmacokinetic parameters in patients treated with oral mexiletine. Eur J Clin Pharmacol. 1982;23(5):445–451. doi: 10.1007/BF00605996. [DOI] [PubMed] [Google Scholar]
  30. Wang H. W., Jackson R. T. Effects of lidocaine and procaine on canine nasal blood vessels. Ann Otol Rhinol Laryngol. 1988 Jul-Aug;97(4 Pt 1):409–413. doi: 10.1177/000348948809700415. [DOI] [PubMed] [Google Scholar]
  31. Willman C., Hendrickson H. S. Positive surface charge inhibition of phospholipase A2 in mixed monolayer systems. Arch Biochem Biophys. 1978 Nov;191(1):298–305. doi: 10.1016/0003-9861(78)90092-9. [DOI] [PubMed] [Google Scholar]
  32. Woosley R. L., Wang T., Stone W., Siddoway L., Thompson K., Duff H. J., Cerskus I., Roden D. Pharmacology, electrophysiology, and pharmacokinetics of mexiletine. Am Heart J. 1984 May;107(5 Pt 2):1058–1065. doi: 10.1016/0002-8703(84)90175-3. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES